Petauri Evidence is an innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, along with Petauri’s US HEOR business. Together, we are dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making.
At Petauri Evidence, we partner with Pharma and Medtech leaders to drive optimal global commercialisation. Programmes of support include: • Evidence, pricing and access strategy • Development of a robust evidence base • National, regional, and local reimbursement, and formulary inclusion • Communication of value to clinical and financial decision-makers Our clients benefit from collaborative, expert-driven, solutions-focused partnerships.
We challenge and inspire them to achieve the best results, applying innovation and agility to everything we do. We have extensive experience in all therapy areas and deep expertise in rare disease, oncology, respiratory, diabetes and obesity, neurology, and immunology.